SHOC2 and liver cancer: Within two in-vivo liver cancer models, we found that in DEN-HFD (diethylnitrosamine plus a high-fat diet) model, hepatocyte-specific Shoc2 deletion deactivates the Ras-Mapk signal without affecting the mTorc1 signals but has no effect in the progression of liver tumorigenesis.